Hemostats hold three major functions, especially in the emergency wound care. The hemostats were initially designed to compress the smaller blood vessels for the control of hemorrhage. Another major use of hemostats is to grasp and give optimal security superficial fascia in debriding and undermining wounds. Ultimately, hemostats turned out to be a brilliant tool for exploring, exposing, as well as visualizing the deep areas of any wound. There are two main types of hemostats that are commonly used in wound care. For the general use, the standard or the regular hemostat is advised. For the smaller wounds, finer work is mostly recommended which is used in combination with 5-inch curved mosquito hemostat along with fine serrated jaws.
Hemostatic agents market was estimated to be over US$ 3 Bn in 2018. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.
Surge in the number of surgical procedures conducted globally is expected to contribute towards the growth of the hemostatic agents market. The growth of the global market is further fueled by factors such as rising adoption of hemostats to restrain bleeding, rise in geriatric population requiring surgical procedures for various ailments, growing research and development activities worldwide. Owing to the growing demand for hemostatic agents that are quicker and cheaper, there is a remarkable opportunity for the key players in the hemostatic agents market to fill in this gap. Allergic reactions to human plasma or animal derived component in the hemostatic agents is anticipated to hamper the growth of this market.
Major Key Players of the Hemostatic Agents Market are:
Baxter, Ethicon US, C. R. Bard, B. Braun Melsungen AG, Pfizer, Z-Medica, CryoLife, Integra LifeSciences, Advanced Medical Solutions Group plc. GELITA AG.
No comments:
Post a Comment